Subcellular and extracellular localization of specific binding sites for triphenylethylene antiestrogens in human breast cancer

Alberto Gulino, Alessandra Vacca, Andrea Modesti, Isabella Screpanti, Antonietta Farina, Luigi Frati

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

MCF-7 human breast cancer cell homogenates and subcellular organelles were submitted to isopycnic centrifugation on Percoll gradients to investigate the subcellular localization of triphenylethylene antiestrogen specific binding sites (AEBS). Electron microscopy revealed that gradient fractions coincident with the migration of [3H]tamoxifen-AEBS complexes were homogeneously represented by rough and smooth endoplasmic reticulum. Eighty percent of AEBS were localized in the endoplasmic reticulum [45,000 ± 4,000 sites/cell, mean ± S.D.), while 20% of these sites were also found in the nuclear fraction (12,000 ± 1,000 sites/cell, mean ± S.D.). A similar subcellular distribution of AEBS was observed in human breast cancer bioptic specimens. No differences in [3H]tamoxifen binding affinity between microsomal and nuclear AEBS were observed in MCF-7 and bioptic breast cancer. No major differences in microsomal AEBS levels were observed in the limited number of estrogen receptor-positive or -negative breast cancer specimens we have studied, whereas estrogen receptor-negative samples had higher levels of nuclear AEBS with respect to estrogen receptor-positive tumors. The presence of AEBS was also detected in the human serum of healthy and tumor-bearing subjects. The affinity and the binding specificity of serum AEBS were similar to those of intracellular AEBS. No differences in the levels of serum AEBS were observed between healthy and tumor-bearing subjects [19 ± 4 and 22 ± 4 pmoles/ml (mean ± S.D.) respectively. Human serum AEBS did not appear to be associated to lipoproteins, whereas it migrated as a 5.5 S sedimenting molecule.

Original languageEnglish
Pages (from-to)3863-3870
Number of pages8
JournalBiochemical Pharmacology
Volume35
Issue number21
DOIs
Publication statusPublished - Nov 1 1986

Fingerprint

Estrogen Receptor Modulators
Binding Sites
Breast Neoplasms
Bearings (structural)
Estrogen Receptors
Tumors
Tamoxifen
Serum
triphenylethylene
Isopycnic Centrifugation
Smooth Endoplasmic Reticulum
Neoplasms
Centrifugation
Rough Endoplasmic Reticulum
Endoplasmic Reticulum
Organelles
Electron microscopy
Lipoproteins
Electron Microscopy
Cells

ASJC Scopus subject areas

  • Pharmacology

Cite this

Subcellular and extracellular localization of specific binding sites for triphenylethylene antiestrogens in human breast cancer. / Gulino, Alberto; Vacca, Alessandra; Modesti, Andrea; Screpanti, Isabella; Farina, Antonietta; Frati, Luigi.

In: Biochemical Pharmacology, Vol. 35, No. 21, 01.11.1986, p. 3863-3870.

Research output: Contribution to journalArticle

Gulino, Alberto ; Vacca, Alessandra ; Modesti, Andrea ; Screpanti, Isabella ; Farina, Antonietta ; Frati, Luigi. / Subcellular and extracellular localization of specific binding sites for triphenylethylene antiestrogens in human breast cancer. In: Biochemical Pharmacology. 1986 ; Vol. 35, No. 21. pp. 3863-3870.
@article{ae12f932026a4bb89328b2381ce02d80,
title = "Subcellular and extracellular localization of specific binding sites for triphenylethylene antiestrogens in human breast cancer",
abstract = "MCF-7 human breast cancer cell homogenates and subcellular organelles were submitted to isopycnic centrifugation on Percoll gradients to investigate the subcellular localization of triphenylethylene antiestrogen specific binding sites (AEBS). Electron microscopy revealed that gradient fractions coincident with the migration of [3H]tamoxifen-AEBS complexes were homogeneously represented by rough and smooth endoplasmic reticulum. Eighty percent of AEBS were localized in the endoplasmic reticulum [45,000 ± 4,000 sites/cell, mean ± S.D.), while 20{\%} of these sites were also found in the nuclear fraction (12,000 ± 1,000 sites/cell, mean ± S.D.). A similar subcellular distribution of AEBS was observed in human breast cancer bioptic specimens. No differences in [3H]tamoxifen binding affinity between microsomal and nuclear AEBS were observed in MCF-7 and bioptic breast cancer. No major differences in microsomal AEBS levels were observed in the limited number of estrogen receptor-positive or -negative breast cancer specimens we have studied, whereas estrogen receptor-negative samples had higher levels of nuclear AEBS with respect to estrogen receptor-positive tumors. The presence of AEBS was also detected in the human serum of healthy and tumor-bearing subjects. The affinity and the binding specificity of serum AEBS were similar to those of intracellular AEBS. No differences in the levels of serum AEBS were observed between healthy and tumor-bearing subjects [19 ± 4 and 22 ± 4 pmoles/ml (mean ± S.D.) respectively. Human serum AEBS did not appear to be associated to lipoproteins, whereas it migrated as a 5.5 S sedimenting molecule.",
author = "Alberto Gulino and Alessandra Vacca and Andrea Modesti and Isabella Screpanti and Antonietta Farina and Luigi Frati",
year = "1986",
month = "11",
day = "1",
doi = "10.1016/0006-2952(86)90677-5",
language = "English",
volume = "35",
pages = "3863--3870",
journal = "Biochemical Pharmacology",
issn = "0006-2952",
publisher = "Elsevier Inc.",
number = "21",

}

TY - JOUR

T1 - Subcellular and extracellular localization of specific binding sites for triphenylethylene antiestrogens in human breast cancer

AU - Gulino, Alberto

AU - Vacca, Alessandra

AU - Modesti, Andrea

AU - Screpanti, Isabella

AU - Farina, Antonietta

AU - Frati, Luigi

PY - 1986/11/1

Y1 - 1986/11/1

N2 - MCF-7 human breast cancer cell homogenates and subcellular organelles were submitted to isopycnic centrifugation on Percoll gradients to investigate the subcellular localization of triphenylethylene antiestrogen specific binding sites (AEBS). Electron microscopy revealed that gradient fractions coincident with the migration of [3H]tamoxifen-AEBS complexes were homogeneously represented by rough and smooth endoplasmic reticulum. Eighty percent of AEBS were localized in the endoplasmic reticulum [45,000 ± 4,000 sites/cell, mean ± S.D.), while 20% of these sites were also found in the nuclear fraction (12,000 ± 1,000 sites/cell, mean ± S.D.). A similar subcellular distribution of AEBS was observed in human breast cancer bioptic specimens. No differences in [3H]tamoxifen binding affinity between microsomal and nuclear AEBS were observed in MCF-7 and bioptic breast cancer. No major differences in microsomal AEBS levels were observed in the limited number of estrogen receptor-positive or -negative breast cancer specimens we have studied, whereas estrogen receptor-negative samples had higher levels of nuclear AEBS with respect to estrogen receptor-positive tumors. The presence of AEBS was also detected in the human serum of healthy and tumor-bearing subjects. The affinity and the binding specificity of serum AEBS were similar to those of intracellular AEBS. No differences in the levels of serum AEBS were observed between healthy and tumor-bearing subjects [19 ± 4 and 22 ± 4 pmoles/ml (mean ± S.D.) respectively. Human serum AEBS did not appear to be associated to lipoproteins, whereas it migrated as a 5.5 S sedimenting molecule.

AB - MCF-7 human breast cancer cell homogenates and subcellular organelles were submitted to isopycnic centrifugation on Percoll gradients to investigate the subcellular localization of triphenylethylene antiestrogen specific binding sites (AEBS). Electron microscopy revealed that gradient fractions coincident with the migration of [3H]tamoxifen-AEBS complexes were homogeneously represented by rough and smooth endoplasmic reticulum. Eighty percent of AEBS were localized in the endoplasmic reticulum [45,000 ± 4,000 sites/cell, mean ± S.D.), while 20% of these sites were also found in the nuclear fraction (12,000 ± 1,000 sites/cell, mean ± S.D.). A similar subcellular distribution of AEBS was observed in human breast cancer bioptic specimens. No differences in [3H]tamoxifen binding affinity between microsomal and nuclear AEBS were observed in MCF-7 and bioptic breast cancer. No major differences in microsomal AEBS levels were observed in the limited number of estrogen receptor-positive or -negative breast cancer specimens we have studied, whereas estrogen receptor-negative samples had higher levels of nuclear AEBS with respect to estrogen receptor-positive tumors. The presence of AEBS was also detected in the human serum of healthy and tumor-bearing subjects. The affinity and the binding specificity of serum AEBS were similar to those of intracellular AEBS. No differences in the levels of serum AEBS were observed between healthy and tumor-bearing subjects [19 ± 4 and 22 ± 4 pmoles/ml (mean ± S.D.) respectively. Human serum AEBS did not appear to be associated to lipoproteins, whereas it migrated as a 5.5 S sedimenting molecule.

UR - http://www.scopus.com/inward/record.url?scp=0022974994&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022974994&partnerID=8YFLogxK

U2 - 10.1016/0006-2952(86)90677-5

DO - 10.1016/0006-2952(86)90677-5

M3 - Article

C2 - 3778510

AN - SCOPUS:0022974994

VL - 35

SP - 3863

EP - 3870

JO - Biochemical Pharmacology

JF - Biochemical Pharmacology

SN - 0006-2952

IS - 21

ER -